All publications

High shear blending with glyceryl distearate provides individually coated drug particles for effective taste masking

  • Scientific publication

Journal of Drug Delivery Science and Technology, Volume 48, Pages 437-449 - Dec 2018

Yvonne Rosiaux, Amandine Forest, Jean-Michel Girard, Carole Deleglise, Liz Sheehan and Delphine Marchaud

In this study the authors used:
– A design of experiment, to evaluate the effect of process parameters (blending speed, chopper speed and coating time) on drug particle size.
– Potassium chloride as model drug.

The study showed:
– Individual particle coating was achieved at 450 rpm with 20% glyceryl distearate (Precirol® ATO 5) at 48°C
– High shear coating is as efficient as fluid bed coating for taste masking
– A trained sensory panel confirmed the effectiveness of the process on taste masking

Skin Penetration and Permeation Properties of Transcutol®—Neat or Diluted Mixtures

  • Scientific publication

AAPS PharmSciTech, Vol. 19, No.8 DOI: 10.1208/s12249-018-1196-8 - Nov 2018

David W. Osborne and Jasmine Musakhanian

In this critical article, the authors have reviewed numerous studies in order to elucidate the mechanism of action of the highly purified diethylene glycol monoethyl ether TRANSCUTOL® on skin penetration and permeation.

An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems

  • Scientific publication

Pharmaceutical Research volume 36, Article number: 4 doi: 10.1007/s11095-018-2531-1. - Nov 2018

Vithani K, Goyanes A, Jannin V, Basit AW, Gaisford S, Boyd BJ.

In this review article, the authors describe the various technologies used for 3D printing and their application in the pharmaceutical field.

The potential for lipids and the opportunities for lipid-based drug delivery systems are highlighted.

Evolution of the Microstructure of Sustained-release Matrix Tablets during Dissolution and Storage

  • Scientific publication

Indian J Pharm Sci 2018;80(6):1011-1020 - Sep 2018

V. Jannin, E. Leccia, Y. Rosiaux, J. Doucet

Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS

  • Scientific publication

European Journal of Pharmaceutics and Biopharmaceutics, Volume 130, Pages 236-246 - Sep 2018

Kapilkumar Vithani, Adrian Hawley, Vincent Jannin, Colin Pouton, Ben J. Boyd

Development of a daphnetin transdermal patch using chemical enhancer strategy: insights of the enhancement effect of Transcutol P and the assessment of pharmacodynamics.

  • Scientific publication

Drug Dev Ind Pharm. 2018 Oct;44(10):1642-1649. doi: 10.1080/03639045.2018.1483391. Epub 2018 Jul 2. - Jul 2018

Shen M, Liu C, Wan X, Farah N, Fang L.

A patch for transdermal delivery of daphnetin was developed using Transcutol® P as permeation enhancer.

The study showed:


10% Transcutol® P led to a significant increase in drug release from the patch.
Patch exhibited analgesic and anti-inflammatory activity

Gels, crèmes, formes semi-solides : de leur développement à leur enregistrement. [Gels, creams, semi-solid forms: from their development to their registration]

  • Scientific publication

STP Pharma Pratiques – September October 2018 – 28(5) 181-250 – ISSN 1157-1497 - 2018

E. Beyssac, V. Boudy, E. Dauphin-Chanard, S. Delehouzé, L. Frances, B. Gos, C. Lacaze, V. Laffineur, A. Mestres, I. Ribeiro Dos Santos, X. Thomas and N. Zeng

The SFSTP commission on topical dosage forms published an article reviewing all the steps for their development to registration.

Interestingly this article is both in French and English languages.

Table of content:

 

Introduction

I Definition of a semi-solid

II Tests and studies applicable in evaluation of semi-solid forms from development up to the phase of routine use

2.1 Regulatory requirements
2.2 Relevant tests in development
    2.2.1 Conventional characterization tests
    2.2.2 Characterization tests specified to evaluate performance of the formulation
    2.2.3 Additional characterization tests specified to evaluate performance of the formulation

III QbD approach related to the formulation

3.1 Different elements of the QbD
3.2 When to set up QbD ?
3.3 Definition of QTPP
3.4 CQAs toward evaluation of risks of process
3.5 Example of CMAs studied in case of a semi-solid formulation
3.6 Example of CPPs studied in case of a semi-solid formulation

Conclusion
IV Conclusions and perspectives

Lipid-based nanosuspensions for oral delivery of peptides, a critical review

  • Scientific publication

International Journal of Pharmaceutics, Volume 541, Issues 1–2, Pages 117–135 - Apr 2018

Camille Dumont, Sandrine Bourgeois, Hatem Fessi, Vincent Jannin

In this review article, the authors describe:


the different techniques used to prepare Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
the methods used to assess the protective effects of the carriers on peptides


the techniques used to measure the permeability enhancement

Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating

  • Scientific publication

International Journal of Pharmaceutics, Volume 538, Issues 1–2, Pages 159-166 - Mar 2018

Janine Griesser, Gergely Hetényi, Hatice Kadas, Frédéric Demarne, Vincent Jannin and Andreas Bernkop-Schnürch

The aim of this study was to evaluate the mucus permeating properties of self-emulsifying drug delivery systems (SEDDS). Small droplet size and negative zeta potential of SEDDS could be identified as key parameters for their mucus permeating properties.